The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
These reactions should go away on their own within a few days of injecting your Zepbound dose. But, if you experience a reaction that’s severe or bothersome to you, talk with your doctor.
The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...
The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...
Wegovy and Ozempic are the exact same drug: semaglutide. They are dosed slightly differently and marketed for different ...
She said she initially paid $300 per month for the compound drug and now pays $350 for a higher dose. Hunt's insurance does not cover Zepbound. But she qualifies for Eli Lilly's savings card ...